Guardian Pharmacy Services (NYSE:GRDN) Trading Down 5% - What's Next?

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report)'s stock price traded down 5% on Thursday . The company traded as low as $19.23 and last traded at $19.24. 140,536 shares were traded during trading, a decline of 26% from the average session volume of 189,088 shares. The stock had previously closed at $20.26.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. Raymond James started coverage on shares of Guardian Pharmacy Services in a research note on Monday, October 21st. They set an "outperform" rating and a $21.00 target price for the company. Truist Financial raised their price objective on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a "buy" rating in a research report on Friday, November 15th. Finally, Stephens initiated coverage on Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They issued an "overweight" rating and a $21.00 target price on the stock.

Guardian Pharmacy Services Stock Performance

The stock's 50 day simple moving average is $21.82.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($2.19). The firm had revenue of $314.39 million for the quarter, compared to analysts' expectations of $303.21 million. On average, analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Insider Transactions at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Steven D. Cosler purchased 7,000 shares of the firm's stock in a transaction that occurred on Tuesday, November 19th. The stock was purchased at an average cost of $21.22 per share, with a total value of $148,540.00. Following the purchase, the director now owns 17,713 shares of the company's stock, valued at approximately $375,869.86. The trade was a 65.34 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Institutional Trading of Guardian Pharmacy Services

Hedge funds and other institutional investors have recently bought and sold shares of the business. Stephens Inc. AR bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at approximately $189,000. Virtu Financial LLC bought a new stake in Guardian Pharmacy Services during the 3rd quarter valued at $279,000. Barclays PLC bought a new stake in Guardian Pharmacy Services during the 3rd quarter valued at $311,000. Point72 DIFC Ltd purchased a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth $573,000. Finally, Royce & Associates LP bought a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth $1,260,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.